Back

Novel oral pathways in LDL-c lowering therapy: the new promise of oral CETP inhibitors

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: The LDL-c challenge in patients with high cardiovascular risk: integrating innovative therapies in clinical management Lipid-Lowering Agents Open Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Erin Michos

The Johns Hopkins University School of Medicine, Baltimore (United States of America)

5 More presentations in this session

Presentation thumbnail
Introduction
Professor J. Kastelein (Amsterdam, NL)
Slides Video
Presentation thumbnail
The evolving need and challenges to reach LDL-c targets in high-risk patients
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Oral LDL-c lowering therapies - the basis of prevention
Professor L. Tokgozoglu (Ankara, TR)
Slides Video
Presentation thumbnail
PCSK9i: expanding benefits across the spectrum of cardiovascular disease
Professor F. Martens (Amsterdam, NL)
Slides Video
Presentation thumbnail
Discussion
Professor K. Ray (London, GB) Professor J. Kastelein (Amsterdam, NL) Professor F. Martens (Amsterdam, NL) Professor E. Michos (Baltimore, US)
Video

Access the full session

Session thumbnail
The LDL-c challenge in patients with high cardiovascular risk: integrating innovative therapies in clinical management
Video

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Effects of lipid-lowering therapies on lipoprotein(a) levels in patients with dyslipidemia: a systematic review and network meta-analysis of 64 randomised controlled trials
thumbnail
Congress Presentation
Where are we now? Decision-making in LDL-C lowering and CV risk
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources